A 'Bellwether' Year for Life Sciences: Lawyers Forecast M&A Uptick as Regs Remain Busy
The IPO window doesn’t appear to be opening anytime soon, but life sciences lawyers expect mergers—and regulatory challenges—to pick up this year.
The IPO window doesn’t appear to be opening anytime soon, but life sciences lawyers expect mergers—and regulatory challenges—to pick up this year.